Answers are grounded in this paper and cite their sources.
Observed ANC consultations and L & D cases showed low use of WHO-recommended practices for PE/E screening and management. Availability of MgSO4 was low in multiple countries, though it was on the essential drug list of all surveyed countries. Country programs are encouraged to address gaps in screening and management of PE/E in ANC and L & D to contribute to lower maternal and perinatal mortality.
No takes yet. Share an insight, caveat, or question.
Rawlins et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: